Skip to content

Septerna, Inc. SEPN Total Equity

Total Equity at other companies

Amgen logo
AmgenAMGN
$9.19B+48.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$394.88M+12.8%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$471.51M+65.0%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$480.89M0.0%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$525.9M-38.8%
Precigen logo
PrecigenPGEN
$20.24M+244%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s total equity?
Septerna, Inc. (SEPN) reported total equity of $378.46M in Q1 2026.
How has Septerna, Inc.'s total equity changed year-over-year?
Septerna, Inc.'s total equity increased by 194.6% year-over-year, from -$400.27M to $378.46M.
What is the long-term trend for Septerna, Inc.'s total equity?
Over 3 years (2022 to 2025), Septerna, Inc.'s total equity has grown at a 105.2% compound annual growth rate (CAGR), from -$44.2M to $381.93M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.